売上高・売上総利益率の推移
| 年度 |
売上高 |
売上総利益率 |
| 2024/12 |
3,955 |
- |
| 2022/12 |
82 |
- |
| 2021/12 |
386 |
- |
| 2020/12 |
1,824 |
- |
| 2019/12 |
1,176 |
- |
| 2018/12 |
963 |
|
営業利益・営業利益率の推移
| 年度 |
営業利益 |
営業利益率 |
| 2024/12 |
-25,144 |
-635.8% |
| 2023/12 |
-26,743 |
- |
| 2022/12 |
-14,029 |
-17207.5% |
| 2021/12 |
-18,746 |
-4862.7% |
| 2020/12 |
-2,817 |
-154.5% |
| 2019/12 |
-2,372 |
|
| 2018/12 |
-2,563 |
|
| 2017/12 |
-2,174 |
|
| 2016/12 |
-3,273 |
|
| 2015/12 |
-2,695 |
|
| 2014/12 |
-2,738 |
|
| 2013/12 |
-2,289 |
|
| 2012/12 |
-2,139 |
|
| 2011/12 |
-2,349 |
|
|
(単位:千ドル)
|
2011/12
|
2012/12
|
2013/12
|
2014/12
|
2015/12
|
2016/12
|
2017/12
|
2018/12
|
2019/12
|
2020/12
|
2021/12
|
2022/12
|
2023/12
|
2024/12
|
|
売上高
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
963
|
1,175
|
1,823
|
385
|
81
|
-
|
3,954
|
|
売上成長率(%)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
55.1
|
-78.9
|
-78.9
|
-
|
-
|
|
研究開発費
|
25,630
|
28,674
|
31,589
|
1,812
|
1,693
|
1,970
|
2,017
|
1,878
|
1,910
|
2,444
|
15,554
|
9,123
|
20,720
|
23,713
|
|
営業費用
|
43,278
|
48,074
|
52,781
|
3,620
|
3,122
|
4,102
|
3,249
|
3,525
|
3,548
|
4,640
|
19,131
|
14,110
|
26,742
|
29,098
|
|
営業利益
|
-2,350
|
-2,139
|
-2,290
|
-2,738
|
-2,695
|
-3,274
|
-2,175
|
-2,563
|
-2,373
|
-2,817
|
-18,746
|
-14,029
|
-26,743
|
-25,145
|
|
営業利益率 (%)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
|
-154.5
|
-4862.7
|
-17207.5
|
-
|
-635.8
|
|
純利益
|
-2,347
|
-2,136
|
-2,285
|
-2,734
|
-2,690
|
-3,272
|
-2,171
|
-2,561
|
-2,371
|
-2,959
|
-18,571
|
-14,022
|
-25,967
|
-24,993
|
|
純利益率(%)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
|
-162.2
|
-4817.2
|
-17198.3
|
-
|
-632.0
|
|
一株あたり利益
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.83
|
-14.29
|
-4.82
|
|
希薄化後一株あたり利益
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.83
|
-14.29
|
-4.82
|
|
EBITDA
|
|
|
|
|
|
|
|
|
|
-2,798
|
-18,708
|
-13,973
|
-26,669
|
-25,049
|
|
EBITDAマージン(%)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
|
-153.4
|
-4852.7
|
-17138.4
|
-
|
-633.4
|